LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,487,000 | -23.8% | 1,500,000 | 0.0% | 0.50% | -23.8% |
| Q1 2021 | $1,951,000 | +35.9% | 1,500,000 | 0.0% | 0.66% | +8.9% |
| Q4 2020 | $1,436,000 | +4.9% | 1,500,000 | 0.0% | 0.61% | -16.3% |
| Q3 2020 | $1,369,000 | +4.7% | 1,500,000 | 0.0% | 0.73% | -15.8% |
| Q2 2020 | $1,308,000 | +4.6% | 1,500,000 | 0.0% | 0.86% | -32.7% |
| Q1 2020 | $1,250,000 | – | 1,500,000 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |